Jeff Bezos backed Grail before it lost half its value. Here's whether he was early -- or just wrong.

The fate of Grail's stock will ultimately be decided in the cost-benefit calculations of medical insurers.
Ottawa CitizenOpinion

He thought he was healthy. Ontario hopes earlier screening will catch cancers like his

He was diagnosed with Stage 3B colorectal cancer. The cancer had spread to two lymph nodes. He then underwent six months of ...

Will Expanded Coverage of Guardant’s Shield Test Reshape UnitedHealth Group’s (UNH) Preventive Care Narrative?

In July 2026, Guardant Health announced that its Shield blood test for colorectal cancer screening is now covered for ...